LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article ; Online: Left atrial appendage occlusion

    Ignacio Cruz-González / David González-Calle

    REC: Interventional Cardiology (English Ed.), Vol 1, Iss 2, Pp 89-

    a decade of evidence

    2021  Volume 90

    Abstract: Over the last few years, left atrial appendage occlusion (LAAO) has gained traction in patients with nonvalvular atrial fibrillation as an alternative to oral anticoagulation to prevent cerebral infarction, especially in patients with some sort of ... ...

    Abstract Over the last few years, left atrial appendage occlusion (LAAO) has gained traction in patients with nonvalvular atrial fibrillation as an alternative to oral anticoagulation to prevent cerebral infarction, especially in patients with some sort of contraindication to these drugs.1 In an article published in REC: Interventional Cardiology, Ruiz-Salmerón et al.2 describe their experience using this technique during the last 10 years. This publication gives us the opportunity to review the cumulative scientific evidence available in this regard that has justified its exponential growth. In the last national registry published in the United States, the number of physicians and hospitals that perform this intervention has gone from 30 to over 1200 and from 20 to over 400, respectively, within the last 2 years.3 In Spain, according to the registry published by the Interventional Cardiology Association of the Spanish Society of Cardiology, .
    Keywords Medicine ; R
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Cierre percutáneo de la orejuela izquierda

    Ignacio Cruz-González / David González-Calle

    REC: Interventional Cardiology, Vol 3, Iss 2, Pp 89-

    una década de evidencias

    2021  Volume 90

    Abstract: El cierre percutáneo de la orejuela izquierda (COI) se ha establecido en los últimos años, en los pacientes con fibrilación auricular no valvular, como una alternativa a la anticoagulación oral para la prevención del infarto cerebral, en especial en ... ...

    Abstract El cierre percutáneo de la orejuela izquierda (COI) se ha establecido en los últimos años, en los pacientes con fibrilación auricular no valvular, como una alternativa a la anticoagulación oral para la prevención del infarto cerebral, en especial en aquellos pacientes con algún tipo de contraindicación para la toma de estos fármaco1. En un artículo publicado en REC: Interventional Cardiology, Ruiz-Salmerón et al.2 describen su experiencia con esta técnica en los últimos 10 años. Esta publicación nos brinda la oportunidad de revisar la evidencia acumulada en esta década y que justifica su extraordinario crecimiento. En el último registro nacional en los Estados Unidos, el número de médicos y de hospitales que realizan esta intervención ha pasado de 30 a más de 1.200 y de 20 a más de 400, respectivamente, en los últimos 2 años3. En .
    Keywords Internal medicine ; RC31-1245
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Left atrial appendage occlusion

    Ignacio Cruz-González / David González-Calle

    REC: Interventional Cardiology (English Ed.), Vol 3, Iss 2, Pp 89-

    a decade of evidence

    2021  Volume 90

    Abstract: Over the last few years, left atrial appendage occlusion (LAAO) has gained traction in patients with nonvalvular atrial fibrillation as an alternative to oral anticoagulation to prevent cerebral infarction, especially in patients with some sort of ... ...

    Abstract Over the last few years, left atrial appendage occlusion (LAAO) has gained traction in patients with nonvalvular atrial fibrillation as an alternative to oral anticoagulation to prevent cerebral infarction, especially in patients with some sort of contraindication to these drugs.1 In an article published in REC: Interventional Cardiology, Ruiz-Salmerón et al.2 describe their experience using this technique during the last 10 years. This publication gives us the opportunity to review the cumulative scientific evidence available in this regard that has justified its exponential growth. In the last national registry published in the United States, the number of physicians and hospitals that perform this intervention has gone from 30 to over 1200 and from 20 to over 400, respectively, within the last 2 years.3 In Spain, according to the registry published by the Interventional Cardiology Association of the Spanish Society of Cardiology,.
    Keywords Medicine ; R
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Mitral Paravalvular Leak

    Ignacio Cruz-Gonzalez / Pablo Antunez-Muiños / Sergio Lopez-Tejero / Pedro L. Sanchez

    Journal of Clinical Medicine, Vol 11, Iss 1245, p

    Clinical Implications, Diagnosis and Management

    2022  Volume 1245

    Abstract: Paravalvular leak incidence after mitral surgical replacement ranges from 7% to 17%. Between 1% and 5% of these are clinically significant. Large PVLs can cause important clinical manifestations such as heart failure or haemolysis. Current guidelines ... ...

    Abstract Paravalvular leak incidence after mitral surgical replacement ranges from 7% to 17%. Between 1% and 5% of these are clinically significant. Large PVLs can cause important clinical manifestations such as heart failure or haemolysis. Current guidelines consider that surgical reparation is the gold-standard therapy in symptomatic patients with paravalvular leak. However, these recommendations are based in non-randomized observational registries. On the other hand, transcatheter paravalvular leak closure has shown excellent results with a low rate of complications, and nowadays it is considered the first option in selected patients in some experienced centres. In this review, we summarize the clinical manifestations, diagnosis, procedural details, and results of transcatheter mitral PVL closure.
    Keywords paravalvular leaks ; mitral regurgitation ; heart failure and haemolytic anaemia ; valvular prosthesis ; percutaneous closure ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2022-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Insuficiencia mitral a través del dispositivo LAmbre

    Manuel Barreiro-Pérez / María Elena Tundidor-Sanz / Ignacio Cruz-González

    REC: Interventional Cardiology, Vol 1, Iss 3, Pp 207- (2019)

    2019  

    Abstract: Mujer de 83 años con insuficiencia mitral (IM) grave asintomática hospitalizada para ser intervenida de cierre percutáneo de la orejuela izquierda tras haber sufrido una hemorragia gastrointestinal grave mientras estaba bajo tratamiento anticoagulante. ... ...

    Abstract Mujer de 83 años con insuficiencia mitral (IM) grave asintomática hospitalizada para ser intervenida de cierre percutáneo de la orejuela izquierda tras haber sufrido una hemorragia gastrointestinal grave mientras estaba bajo tratamiento anticoagulante. La ecocardiografía transesofágica (ETE) realizada previa a la intervención confirmó la presencia de IM grave por flail en segmento P2 y con un chorro regurgitante que se deslizaba por la pared auricular hacia la orejuela. El cierre de la orejuela se llevó a cabo desplegando con éxito el sistema LAmbre (Lifetech Scientific). Una primera valoración confirmó la presencia de una fuga de IM sobre el lóbulo externo del dispositivo (figura 1A; AI: aurícula izquierda; VI: ventrículo izquierdo), si bien un examen mas detallado detectó una vía de fuga de insuficiencia mitral debajo del dispositivo utilizado para el cierre de la orejuela (figura 1B,C). La ETE en 3D del festón P2 de la válvula mitral (*) se muestra en la figura 1D-F (RAo: raíz aórtica; dispositivo de cierre de la orejuela (#); el volumen en 3D está recortado según la línea roja para crear la figura E). La imagen fluoroscópica previa al dispositivo LAmbre se muestra en la figura G. Los pasos de esta intervención pueden seguirse en.
    Keywords Internal medicine ; RC31-1245
    Language English
    Publishing date 2019-08-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Eccentric mitral regurgitation through the LAmbre closure device

    Manuel Barreiro-Pérez / María Elena Tundidor-Sanz / Ignacio Cruz-González

    REC: Interventional Cardiology (English Ed.), Vol 1, Iss 3, Pp 207- (2019)

    2019  

    Abstract: An 83-year-old female with severe asymptomatic mitral regurgitation (MR) was admitted for an elective percutaneous left atrial appendage occlusion (LAAO) due to severe gastrointestinal bleeding under anticoagulant treatment. The transesophageal ... ...

    Abstract An 83-year-old female with severe asymptomatic mitral regurgitation (MR) was admitted for an elective percutaneous left atrial appendage occlusion (LAAO) due to severe gastrointestinal bleeding under anticoagulant treatment. The transesophageal echocardiography (TEE) conducted before the procedure confirmed the presence of severe MR due to a flail P2 segment with a jet lesion on the sliding atrial wall adjacent to the appendage. An LAAO procedure was performed and the LAmbre system (Lifetech Scientific) was successfully deployed. A first assessment confirmed the presence of MR jet over the external lobe of the device (figure 1A; LA, left atrium; LV, left ventricle), but detailed scanning detected one MR jet pathway below the LAAO device (figure 1B,C). The 3D-TEE of the mitral valve P2 scallop (*) is shown on figure 1D-F (Ao, aortic root; LAAO device (#); the 3D-volume is cropped according to red line to create figure E). The pre-LAmbre device fluoroscopy image is shown on figure G. The steps of this procedure are available at video 1 of the supplementary data. Device change or relocation were not considered. We thought that a LAmbre device was the best option for a cone-shaped appendage since the external disc is far enough from the mitral.
    Keywords Medicine ; R
    Subject code 600
    Language English
    Publishing date 2019-08-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Impacto de la pandemia de COVID-19 en el implante de prótesis valvular aórtica percutánea en España

    Soledad Ojeda / Pilar Jiménez-Quevedo / Rafael Romaguera / Ignacio Cruz-González / Raúl Moreno

    REC: Interventional Cardiology, Vol 2, Iss 4, Pp 310-

    2020  Volume 312

    Abstract: Sr. Editor: La pandemia de COVID-19 ha producido un cambio drástico en nuestro sistema de salud. La necesidad de tener recursos disponibles para atender el alto volumen de pacientes afectados, la sobrecarga asistencial y la necesidad de limitar la ... ...

    Abstract Sr. Editor: La pandemia de COVID-19 ha producido un cambio drástico en nuestro sistema de salud. La necesidad de tener recursos disponibles para atender el alto volumen de pacientes afectados, la sobrecarga asistencial y la necesidad de limitar la exposición al virus han llevado a implantar medidas extraordinarias, tales como el retraso en la atención de los pacientes con patología crónica y la suspensión, prácticamente total, de procedimientos electivos, como el implante percutáneo de válvula aórtica (TAVI)1. Desde la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (ACI-SEC) se ha realizado una encuesta a los centros del registro español de TAVI con los siguientes objetivos: cuantificar la afectación temporal en el implante de TAVI en nuestro país por la pandemia de COVID-19, analizar la evolución de los pacientes no tratados debido a dicha pandemia, estudiar la incidencia y las consecuencias de la infección en los tratados durante este periodo de tiempo, y valorar los contagios de COVID-19 en la plantilla médica de las unidades de cardiología intervencionista. De los 46 centros integrantes del registro nacional, participaron en el estudio 40 (86,9%). Los parámetros recogidos en dicha encuesta quedan reflejados en la figura 1. Figure 1. Encuesta realizada a los.
    Keywords Internal medicine ; RC31-1245
    Language English
    Publishing date 2020-11-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Transcatheter aortic valve implantation during the current COVID-19 pandemic. Recommendations from the ACI-SEC

    Raúl Moreno / Soledad Ojeda / Rafael Romaguera / Pilar Jiménez-Quevedo / Ignacio Cruz-González

    REC: Interventional Cardiology (English Ed.), Vol 2, Iss 3, Pp 230-

    2020  Volume 231

    Abstract: To the Editor, During the first few months of 2020, a severe acute respiratory syndrome outbreak due to coronavirus 2 (SARS-CoV-2) was an- nounced worldwide. The WHO (World Health Organization) declared the global pandemic in March 11, 2020. After the ... ...

    Abstract To the Editor, During the first few months of 2020, a severe acute respiratory syndrome outbreak due to coronavirus 2 (SARS-CoV-2) was an- nounced worldwide. The WHO (World Health Organization) declared the global pandemic in March 11, 2020. After the United States, to this day Spain remains as the second country with the highest number of patients infected. Apart from the direct consequences of the coronavirus disease 2019 (COVID-19), the healthcare system overload is negatively impacting the effective management of other severe conditions whose treatment can’t wait. During the current COVID-19 pandemic, patients with cardiovascular diseases are suffering diagnostic and treatment delays that are probably impacting cardiovascular mortality.1 Scientific societies have issued several warnings on the management of the acute coronary syndrome and ST-segment elevation myocardial infarction.2
    Keywords Medicine ; R
    Subject code 610
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Impact of the COVID-19 pandemic on transcatheter aortic valve implantation in Spain

    Soledad Ojeda / Pilar Jiménez-Quevedo / Rafael Romaguera / Ignacio Cruz-González / Raúl Moreno

    REC: Interventional Cardiology (English Ed.), Vol 2, Iss 4, Pp 310-

    2020  Volume 312

    Abstract: To the Editor, The current COVID-19 pandemic has changed our health system dramatically. The need to have resources available to assist the high volume of patients affected, the healthcare overload, and the need to limit exposure to the virus have led to ...

    Abstract To the Editor, The current COVID-19 pandemic has changed our health system dramatically. The need to have resources available to assist the high volume of patients affected, the healthcare overload, and the need to limit exposure to the virus have led to the implementation of extraordinary measures like delaying the healthcare provided to patients with chronic conditions and the almost total suspension of elective procedures such as the transcatheter aortic valve implantation (TAVI).1 The Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) sent a survey to the hospitals included in the Spanish TAVI registry with the following objectives: quantify the temporal damage caused by the COVID-19 pandemic to TAVI procedures in our country, analyze the disease progression of patients not treated because of the pandemic, study the rate and consequences of the infection in patients treated during this period of time, and ultimately assess the number of COVID-19 infections within the medical staff of the cath labs. Forty out of the 46 centers included in the national registry participated in the study (86.9%).
    Keywords Medicine ; R
    Language English
    Publishing date 2020-11-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Implante percutáneo de válvula aórtica durante la pandemia de COVID-19. Recomendaciones de la ACI-SEC

    Raúl Moreno / Soledad Ojeda / Rafael Romaguera / Pilar Jiménez-Quevedo / Ignacio Cruz-González

    REC: Interventional Cardiology, Vol 2, Iss 3, Pp 230-

    2020  Volume 231

    Abstract: Sr. Editor: Durante los primeros meses de 2020, se alertó en todo el mundo de la presencia de un brote de coronavirus del síndrome respiratorio agudo grave de tipo 2 (SARS-CoV-2) El 11 de marzo de 2020 la Organización Mundial de la Salud (OMS) declaraba ... ...

    Abstract Sr. Editor: Durante los primeros meses de 2020, se alertó en todo el mundo de la presencia de un brote de coronavirus del síndrome respiratorio agudo grave de tipo 2 (SARS-CoV-2) El 11 de marzo de 2020 la Organización Mundial de la Salud (OMS) declaraba el estado de pandemia mundial. Después de Estados Unidos, España es uno de los países del mundo con mayor número de pacientes infectados. Aparte de las consecuencias directas que provoca la enfermedad coronavírica de 2019 (COVID-19), la sobrecarga del sistema sanitario está afectando negativamente al manejo efectivo de otras patologías graves cuyo tratamiento no debe demorarse. Durante la actual pandemia de COVID-19, los pacientes con cardiopatías están sufriendo retrasos diagnósticos y de tratamiento que muy probablemente se estarán reflejando en la mortalidad cardiovascular1. Las sociedades científicas ya han avisado reiteradamente de los riesgos que se corren en patologías tales como el síndrome coronario agudo y el infarto de miocardio con elevación del segmento ST2. La estenosis aórtica grave (EAG) sintomática tiene mal pronóstico clínico a corto plazo si no se trata. Como el implante percutáneo de válvula aórtica (TAVI) se ha establecido como la opción de tratamiento más habitual para el manejo de la EAG sintomática3, las recomendaciones sobre esta terapia durante la actual pandemia son relevantes a nivel clínico para los médicos que tratan a estos pacientes.
    Keywords Internal medicine ; RC31-1245
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher Permanyer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top